• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

移动应用程序实时评估多发性硬化症患者疲劳及相关症状的可用性:观察性研究。

Usability of a Mobile App for Real-Time Assessment of Fatigue and Related Symptoms in Patients With Multiple Sclerosis: Observational Study.

机构信息

Center for Neurological Imaging, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.

Mobilengine, Budapest, Hungary.

出版信息

JMIR Mhealth Uhealth. 2021 Apr 16;9(4):e19564. doi: 10.2196/19564.

DOI:10.2196/19564
PMID:33861208
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8087974/
Abstract

BACKGROUND

Although fatigue is one of the most debilitating symptoms in patients with multiple sclerosis (MS), its pathogenesis is not well understood. Neurogenic, inflammatory, endocrine, and metabolic mechanisms have been proposed. Taking into account the temporal dynamics and comorbid mood symptoms of fatigue may help differentiate fatigue phenotypes. These phenotypes may reflect different pathogeneses and may respond to different mechanism-specific treatments. Although several tools have been developed to assess various symptoms (including fatigue), monitor clinical status, or improve the perceived level of fatigue in patients with MS, options for a detailed, real-time assessment of MS-related fatigue and relevant comorbidities are still limited.

OBJECTIVE

This study aims to present a novel mobile app specifically designed to differentiate fatigue phenotypes using circadian symptom monitoring and state-of-the-art characterization of MS-related fatigue and its related symptoms. We also aim to report the first findings regarding patient compliance and the relationship between compliance and patient characteristics, including MS disease severity.

METHODS

After developing the app, we used it in a prospective study designed to investigate the brain magnetic resonance imaging correlates of MS-related fatigue. In total, 64 patients with MS were recruited into this study and asked to use the app over a 2-week period. The app features the following modules: Visual Analogue Scales (VASs) to assess circadian changes in fatigue, depression, anxiety, and pain; daily sleep diaries (SLDs) to assess sleep habits and quality; and 10 one-time questionnaires to assess fatigue, depression, anxiety, sleepiness, physical activity, and motivation, as well as several other one-time questionnaires that were created to assess those relevant aspects of fatigue that were not captured by existing fatigue questionnaires. The app prompts subjects to assess their symptoms multiple times a day and enables real-time symptom monitoring through a web-accessible portal.

RESULTS

Of 64 patients, 56 (88%) used the app, of which 51 (91%) completed all one-time questionnaires and 47 (84%) completed all one-time questionnaires, VASs, and SLDs. Patients reported no issues with the usage of the app, and there were no technical issues with our web-based data collection system. The relapsing-remitting MS to secondary-progressive MS ratio was significantly higher in patients who completed all one-time questionnaires, VASs, and SLDs than in those who completed all one-time questionnaires but not all VASs and SLDs (P=.01). No other significant differences in demographics, fatigue, or disease severity were observed between the degrees of compliance.

CONCLUSIONS

The app can be used with reasonable compliance across patients with relapsing-remitting and secondary-progressive MS irrespective of demographics, fatigue, or disease severity.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66d8/8087974/9cfc7719f6e9/mhealth_v9i4e19564_fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66d8/8087974/9c910fb8c607/mhealth_v9i4e19564_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66d8/8087974/2f2120eee36d/mhealth_v9i4e19564_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66d8/8087974/598c85c55d16/mhealth_v9i4e19564_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66d8/8087974/84d3c8aef836/mhealth_v9i4e19564_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66d8/8087974/1acbb96f012f/mhealth_v9i4e19564_fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66d8/8087974/9cfc7719f6e9/mhealth_v9i4e19564_fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66d8/8087974/9c910fb8c607/mhealth_v9i4e19564_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66d8/8087974/2f2120eee36d/mhealth_v9i4e19564_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66d8/8087974/598c85c55d16/mhealth_v9i4e19564_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66d8/8087974/84d3c8aef836/mhealth_v9i4e19564_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66d8/8087974/1acbb96f012f/mhealth_v9i4e19564_fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66d8/8087974/9cfc7719f6e9/mhealth_v9i4e19564_fig6.jpg
摘要

背景

疲劳是多发性硬化症(MS)患者最具致残性的症状之一,但发病机制尚不清楚。神经源性、炎症性、内分泌和代谢机制都被提出来了。考虑到疲劳的时间动态和合并的情绪症状,可能有助于区分疲劳表型。这些表型可能反映了不同的发病机制,并可能对不同的针对特定机制的治疗有反应。尽管已经开发了几种工具来评估各种症状(包括疲劳)、监测临床状况或改善 MS 患者的疲劳感知水平,但对 MS 相关疲劳及其相关症状进行详细、实时评估的选择仍然有限。

目的

本研究旨在介绍一种新的移动应用程序,该应用程序专门通过昼夜节律症状监测和对 MS 相关疲劳及其相关症状的最新特征描述来区分疲劳表型。我们还旨在报告关于患者依从性的第一个发现,以及依从性与患者特征(包括 MS 疾病严重程度)之间的关系。

方法

在开发应用程序后,我们将其用于一项前瞻性研究,旨在调查 MS 相关疲劳的脑磁共振成像相关性。共有 64 名 MS 患者被招募到这项研究中,并要求他们在两周内使用该应用程序。该应用程序具有以下模块:视觉模拟量表(VAS)评估疲劳、抑郁、焦虑和疼痛的昼夜变化;每日睡眠日记(SLD)评估睡眠习惯和质量;以及 10 个一次性问卷评估疲劳、抑郁、焦虑、嗜睡、身体活动和动机,以及几个其他一次性问卷评估疲劳问卷未涵盖的那些与疲劳相关的方面。该应用程序提示患者每天多次评估自己的症状,并通过可访问网络的门户实现实时症状监测。

结果

在 64 名患者中,56 名(88%)使用了该应用程序,其中 51 名(91%)完成了所有一次性问卷,47 名(84%)完成了所有一次性问卷、VAS 和 SLD。患者报告使用该应用程序没有问题,我们的基于网络的数据收集系统也没有出现技术问题。与仅完成所有一次性问卷但未完成所有 VAS 和 SLD 的患者相比,完成所有一次性问卷、VAS 和 SLD 的患者的复发缓解型 MS 到继发进展型 MS 的比例明显更高(P=.01)。在依从性程度方面,没有观察到患者在人口统计学、疲劳或疾病严重程度方面的其他显著差异。

结论

该应用程序可在具有复发缓解型和继发进展型 MS 的患者中合理地使用,无论患者的人口统计学、疲劳或疾病严重程度如何。

相似文献

1
Usability of a Mobile App for Real-Time Assessment of Fatigue and Related Symptoms in Patients With Multiple Sclerosis: Observational Study.移动应用程序实时评估多发性硬化症患者疲劳及相关症状的可用性:观察性研究。
JMIR Mhealth Uhealth. 2021 Apr 16;9(4):e19564. doi: 10.2196/19564.
2
Evaluating the Utility of Smartphone-Based Sensor Assessments in Persons With Multiple Sclerosis in the Real-World Using an App (elevateMS): Observational, Prospective Pilot Digital Health Study.使用应用程序(elevateMS)在真实世界中评估基于智能手机传感器评估对多发性硬化症患者的效用:观察性、前瞻性试点数字健康研究。
JMIR Mhealth Uhealth. 2020 Oct 27;8(10):e22108. doi: 10.2196/22108.
3
Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters.多发性硬化症中的疲劳:不同评定量表的比较及其与临床参数的相关性
Mult Scler. 2002 Dec;8(6):523-6. doi: 10.1191/1352458502ms839oa.
4
Feasibility of a theory-informed mobile app for changing physical activity in youth with multiple sclerosis.一种基于理论的移动应用程序改变多发性硬化症青少年身体活动的可行性研究。
Mult Scler Relat Disord. 2022 Feb;58:103467. doi: 10.1016/j.msard.2021.103467. Epub 2021 Dec 20.
5
A novel disease specific scale to characterize the symptoms and impacts of fatigue in US adults with relapsing multiple sclerosis: A real-world study.一种新的疾病特异性量表,用于描述美国复发型多发性硬化症成年患者疲劳的症状和影响:一项真实世界研究。
Mult Scler Relat Disord. 2022 Mar;59:103637. doi: 10.1016/j.msard.2022.103637. Epub 2022 Jan 29.
6
Feasibility and treatment effect of cognitive behavioral therapy for insomnia in individuals with multiple sclerosis: A pilot randomized controlled trial.多发性硬化症患者失眠的认知行为疗法的可行性和治疗效果:一项初步的随机对照试验。
Mult Scler Relat Disord. 2020 May;40:101958. doi: 10.1016/j.msard.2020.101958. Epub 2020 Jan 23.
7
A Mobile App for Longterm Monitoring of Narcolepsy Symptoms: Design, Development, and Evaluation.用于发作性睡病症状长期监测的移动应用:设计、开发和评估。
JMIR Mhealth Uhealth. 2020 Jan 7;8(1):e14939. doi: 10.2196/14939.
8
Daily collection of self-reporting sleep disturbance data via a smartphone app in breast cancer patients receiving chemotherapy: a feasibility study.通过智能手机应用程序每日收集接受化疗的乳腺癌患者的自我报告睡眠障碍数据:一项可行性研究。
J Med Internet Res. 2014 May 23;16(5):e135. doi: 10.2196/jmir.3421.
9
A mobile app (IDoThis) for multiple sclerosis self-management: development and initial evaluation.一款用于多发性硬化症自我管理的移动应用程序(IDoThis):开发与初步评估。
BMC Med Inform Decis Mak. 2022 Dec 13;22(1):328. doi: 10.1186/s12911-022-02078-z.
10
Sleep quality, daytime sleepiness, fatigue, and quality of life in patients with multiple sclerosis treated with interferon beta-1b: results from a prospective observational cohort study.使用β-1b干扰素治疗的多发性硬化症患者的睡眠质量、日间嗜睡、疲劳及生活质量:一项前瞻性观察性队列研究的结果
BMC Neurol. 2018 Aug 24;18(1):123. doi: 10.1186/s12883-018-1113-5.

引用本文的文献

1
Application of telemedicine in fatigue management for patients with multiple sclerosis: A scoping review.远程医疗在多发性硬化症患者疲劳管理中的应用:一项范围综述。
PLoS One. 2025 Jul 17;20(7):e0327563. doi: 10.1371/journal.pone.0327563. eCollection 2025.
2
Digital Biomarkers and AI for Remote Monitoring of Fatigue Progression in Neurological Disorders: Bridging Mechanisms to Clinical Applications.用于神经疾病疲劳进展远程监测的数字生物标志物与人工智能:连接机制与临床应用
Brain Sci. 2025 May 21;15(5):533. doi: 10.3390/brainsci15050533.
3
A mobile app (IDoThis) for multiple sclerosis self-management: development and initial evaluation.

本文引用的文献

1
Microstructural Changes in the Left Mesocorticolimbic Pathway are Associated with the Comorbid Development of Fatigue and Depression in Multiple Sclerosis.左侧中脑边缘通路的结构变化与多发性硬化症疲劳和抑郁的共病发展有关。
J Neuroimaging. 2021 May;31(3):501-507. doi: 10.1111/jon.12832. Epub 2021 Feb 1.
2
Evaluating the Utility of Smartphone-Based Sensor Assessments in Persons With Multiple Sclerosis in the Real-World Using an App (elevateMS): Observational, Prospective Pilot Digital Health Study.使用应用程序(elevateMS)在真实世界中评估基于智能手机传感器评估对多发性硬化症患者的效用:观察性、前瞻性试点数字健康研究。
JMIR Mhealth Uhealth. 2020 Oct 27;8(10):e22108. doi: 10.2196/22108.
3
一款用于多发性硬化症自我管理的移动应用程序(IDoThis):开发与初步评估。
BMC Med Inform Decis Mak. 2022 Dec 13;22(1):328. doi: 10.1186/s12911-022-02078-z.
4
A Mobile App for Measuring Real Time Fatigue in Patients with Multiple Sclerosis: Introducing the Fimo Health App.一款用于测量多发性硬化症患者实时疲劳程度的移动应用程序:介绍Fimo健康应用程序。
Brain Sci. 2021 Sep 18;11(9):1235. doi: 10.3390/brainsci11091235.
5
A Smartphone-based Application for Self-Management in Multiple Sclerosis.基于智能手机的多发性硬化症自我管理应用程序。
J Healthc Eng. 2021 Jun 16;2021:6749951. doi: 10.1155/2021/6749951. eCollection 2021.
Wearable technologies to measure clinical outcomes in multiple sclerosis: A scoping review.
可穿戴技术在多发性硬化症临床结局测量中的应用:系统评价。
Mult Scler. 2021 Oct;27(11):1643-1656. doi: 10.1177/1352458520946005. Epub 2020 Aug 4.
4
Human-Centered Design Strategies for Device Selection in mHealth Programs: Development of a Novel Framework and Case Study.以人为中心的设计策略在移动医疗项目中的设备选择:新型框架的开发与案例研究。
JMIR Mhealth Uhealth. 2020 May 7;8(5):e16043. doi: 10.2196/16043.
5
Feasibility study of a 10-week community-based program using the WalkWithMe application on physical activity, walking, fatigue and cognition in persons with Multiple Sclerosis.基于社区的使用 WalkWithMe 应用程序对多发性硬化症患者进行 10 周身体活动、步行、疲劳和认知能力的可行性研究。
Mult Scler Relat Disord. 2020 Jul;42:102067. doi: 10.1016/j.msard.2020.102067. Epub 2020 Apr 18.
6
Beyond novelty effect: a mixed-methods exploration into the motivation for long-term activity tracker use.超越新奇效应:对长期使用活动追踪器动机的混合方法探索。
JAMIA Open. 2018 Dec 4;2(1):62-72. doi: 10.1093/jamiaopen/ooy048. eCollection 2019 Apr.
7
A novel classification of fatigue in multiple sclerosis based on longitudinal assessments.一种基于纵向评估的多发性硬化症疲劳新分类。
Mult Scler. 2020 May;26(6):725-734. doi: 10.1177/1352458519898112. Epub 2020 Jan 23.
8
Testing Feasibility of a Mobile Application to Monitor Fatigue in People With Multiple Sclerosis.测试一款用于监测多发性硬化症患者疲劳的移动应用的可行性。
J Neurosci Nurs. 2019 Dec;51(6):331-334. doi: 10.1097/JNN.0000000000000479.
9
History of fatigue in multiple sclerosis is associated with grey matter atrophy.多发性硬化症的疲劳史与灰质萎缩有关。
Sci Rep. 2019 Oct 14;9(1):14781. doi: 10.1038/s41598-019-51110-2.
10
Brain anatomical correlates of fatigue in multiple sclerosis.多发性硬化症患者疲劳的大脑解剖学相关因素。
Mult Scler. 2020 Jun;26(7):751-764. doi: 10.1177/1352458519876032. Epub 2019 Sep 19.